Find out about all the great things Elevate has to offer and how to get the most out of your conference experience. Our Elevate Co-Chairs will provide insight into what you can expect to gain out of attending the conference, highlight important conference locations, go over how to use the Elevate conference app, and other tips and tricks for "elevating" your experience on-site.

Breakfast will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Jeremy Schreiber, MSN, APRN, PMHNP-BC

This presentation is provided by Teva Pharmaceuticals USA, Inc.

Breakfast will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Brittany Albright, MD, MPH; Jeffrey Hansen, MD, LFAPA

This presentation is provided by Johnson & Johnson

Join your peers and faculty for Elevate's Got Talent!

Join our co-chairs as they kick off the conference with energy and excitement—plus a little morning karaoke fun!

What is the secret to building strong patient relationships? And what are your worst-case-scenarios in your practice? This interactive session equips mental health clinicians with practical strategies to enhance your patients' experience, and think outside-the-box about solving problems in your clinical practice. Participants will learn how to build trust and connection with patients, and stay solution-focused when faced with unforeseen challenges. Through engaging storytelling (and a little bit of magic) Rob Anderson will provide strategies that shift focus from obstacles to opportunities, promoting resilience and success in your practice. This session empowers clinicians to build strong patient relationships, and thrive in even the most challenging circumstances.

Enhance your clinical practice with this essential guide to laboratory monitoring in psychiatry. Tailored for early career professionals, this session focuses on identifying when and which labs are necessary for baseline screening, routine monitoring, side effect management, and drug level assessments. Learn how to leverage lab results to uncover comorbid physical health conditions that may impact mental health. Gain actionable insights into implementing evidence-based adjustments to psychiatric treatment plans. Equip yourself with the knowledge to make informed, patient-centered decisions in your practice.

Explore how artificial intelligence is transforming the field of psychiatry in this forward-looking session. Learn about the latest AI-driven tools and technologies designed to enhance mental health care, from predictive analytics and personalized treatment planning to innovative diagnostic aids. Discover practical applications, ethical considerations, and potential challenges associated with integrating AI into clinical practice. Equip yourself with cutting-edge knowledge to stay at the forefront of mental health innovation.

The rise of novel psychoactive substances (NPS) poses significant challenges for clinicians navigating their unpredictable effects and growing prevalence. This session equips early career professionals with essential insights into synthetic cannabinoids, opioids, benzodiazepines, stimulants, dissociatives and plant-based substances like kratom. Attendees will explore evidence-based approaches to screening, acute stabilization, and long-term management, alongside advancements in toxicology and treatment strategies. With an emphasis on the evolving legal landscape and real-world patient cases, this presentation provides the tools to address NPS use confidently and improve patient outcomes.

Stay ahead of the curve in Alzheimer’s care with this comprehensive session on emerging treatment modalities. Explore the latest advancements, including monoclonal antibodies and other innovative therapies, and their implications for clinical practice. Learn practical strategies for integrating these cutting-edge treatments into psychiatric care, addressing both medical and psychosocial needs. Equip yourself with the tools to navigate this evolving landscape and optimize outcomes for patients facing Alzheimer’s disease.

Master the financial side of psychiatric practice with this practical session designed to demystify billing and coding. Tailored for early-career clinician this session provides essential skills for accurate documentation, compliant coding, and maximizing reimbursement while minimizing audit risks. Learn strategies to navigate common billing challenges and streamline administrative processes, empowering you to focus more on patient care. Gain the confidence to optimize your practice’s financial health in today’s complex reimbursement landscape.

Pediatric depression and anxiety disorders represent a growing concern in today's healthcare landscape, with significant implications for the well-being of children and adolescents. This session explores the complex nature of these disorders and the psychopharmacological interventions available for their treatment. It also outlines crucial guidelines for primary care providers to determine when referrals to specialists are warranted. By the end of this session, attendees will have a deeper understanding of pediatric depression and anxiety disorders, the available psychopharmacological treatment options, and a clear framework for making informed decisions about referrals. The goal is to equip providers with the knowledge and confidence needed to improve the mental health outcomes of children and adolescents in their care.

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Brooke Kempf, PMHNP-BC

This presentation is provided by Alkermes

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Amy Belnap, APRN, PMHMP-BC; Andrew J. Cutler, MD; Patient Ambassador, Deanne

This presentation is provided by Neurocrine Biosciences, Inc.

Innovations in schizophrenia treatment are expanding beyond dopamine-centric approaches, opening new avenues for symptom control and improved patient outcomes. This session explores the emerging role of muscarinic acetylcholine receptor modulation as a novel and promising strategy in the management of schizophrenia. Attendees will gain a clear understanding of the underlying neurobiology, review recent clinical findings on both approved and investigational agents, and examine how muscarinic receptor activators may be integrated into comprehensive, patient-centered treatment plans. Practical considerations for clinical use will be discussed, empowering clinicians to adopt evidence-based, innovative strategies in their practice.

Supported by an educational grant from Bristol-Myers Squibb.

For many patients with major depressive disorder (MDD), monotherapy with an antidepressant is not enough. This focused session will empower clinicians to recognize when an inadequate antidepressant response signals the need for adjunctive intervention. Participants will examine the latest clinical evidence and mechanisms of action behind FDA-approved and emerging atypical antipsychotics (AAPs) for adjunctive use in major depressive disorder (MDD). Practical guidance will be provided on tailoring treatment strategies, navigating common barriers, and enhancing therapeutic outcomes through personalized and evidence-based care.

Supported by an educational grant from Intra-Cellular Therapies, Inc.

This session will challenge common misunderstandings and misconceptions surrounding autism, offering psychiatric professionals a deeper, evidence-based understanding of this complex neurodevelopmental condition. Participants will explore the diverse presentations of autism across the lifespan, debunk pervasive myths, and examine how biases can impact diagnosis and treatment. Through case studies and practical insights, attendees will gain tools to provide more accurate assessments and create inclusive, individualized care plans that empower autistic individuals and their families.

Explore the intersection of mental health, psychotropic medications, and sexual health in this engaging session tailored for early career psychiatric professionals. Learn to identify and address common sexual health issues associated with psychiatric disorders, including their prevalence in conditions like depression, bipolar disorder, anxiety disorders, and schizophrenia. Gain insights into the impact of psychotropic medications on sexual function and discover alternative treatment options to minimize sexual side effects. Develop evidence-based skills for conducting sensitive sexual health assessments and fostering open, patient-centered communication. Empower your practice with strategies to address this critical yet often overlooked aspect of mental health care.

Gain invaluable insights from a panel of mental health clinicians with diverse backgrounds as they share the lessons learned throughout their careers in psychiatry. From navigating large organizational systems to building successful private practices, panelists will offer candid advice and practical strategies, to help you no matter where you are in your career progression. This engaging session provides a unique opportunity to explore the challenges and triumphs of various psychiatric pathways, equipping attendees with actionable wisdom.

Join your peers in the Exhibit Hall to engage with mentors, recruiters, and future employers, and learn about available pharmaceuticals and devices for your practice. Have your CV reviewed by a hiring expert (booth #319), get a professional headshot taken by our photographer (booth #314), and more! Visit the Psych Congress Elevate booth (#220) to register with an exclusive Alumni rate for 2025, and to learn more about our other Psych Congress events. Elevate with the Experts Booth (#329): Jo Hughes, DMSc, PA-C, CAQ-PSY; Desiree Matthews, PMHNP-BC; Jonathan Meyer, MD (Faculty availability subject to change)

Join us after the conference for drinks, games, networking, and meet and greet the faculty! Eat, drink, and mingle with your peers, faculty, and steering committee members. Step into a world of interactive wonder at Electric Playhouse Las Vegas, the city’s ultimate immersive playground inside the Forum Shops at Caesars Palace! Get ready to move, play, and explore as you dive into motion-activated games, mind-bending digital experiences, and larger-than-life interactive art. Whether you’re dodging virtual obstacles, lighting up the floor with every step, or competing in high-energy group challenges, this venue transforms play into an electrifying adventure.

Breakfast will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Erin Crown, MHS, PA-C, CAQ-Psychiatry

This presentation is provided by Bristol Myers Squibb

Join your peers and faculty for Elevate's Got Talent!

Have you ever been listening to an expert mental health clinician present at a national conference and wondered, “What do I need to do to take my career in that direction?” This question, and many more will be answered during ‘Meet the Mentors’, an interactive series of interviews conducted by the conference moderator to kick-off Day 2 of Elevate. Several interviews will be conducted on stage with faculty experts from all different backgrounds, talk show style, and you’ll be surprised by what you’ll learn. You will also have a chance to meet with many of these faculty members and more at the Elevate with the Experts booth in the Exhibit Hall immediately following this morning's session.

Join your peers in the Exhibit Hall to engage with mentors, recruiters, and future employers, and learn about available pharmaceuticals and devices for your practice. Have your CV reviewed by a hiring expert (booth #319), get a professional headshot taken by our photographer (booth #314), and more! Visit the Psych Congress Elevate booth (#220) to register with an exclusive Alumni rate for 2025, and to learn more about our other Psych Congress events. Elevate with the Experts Booth (#329): Brittany B. Albright, MD, MPH; Steven R. Chan, MD, MBA, FAPA, FAMIA; Erin C. Crown, PA-C, CAQ-Psychiatry; Kristin Dambrino, DNP, PMHNP-BC (Faculty availability subject to change) Coffee will also be available in the exhibit hall from 10:35 AM - 11:20 AM.

Timely and accurate identification of tardive dyskinesia (TD) is essential for optimizing outcomes in patients receiving antipsychotic treatment. This interactive session will equip psychiatric clinicians with the practical tools and strategies needed to enhance TD screening, assessment, and ongoing monitoring—whether in-person or via telemedicine. Participants will review validated rating scales and learn to distinguish TD from other movement disorders through a deeper understanding of diagnostic criteria and clinical features. Attendees will leave with actionable knowledge to support early recognition and individualized care of patients with TD.

Supported by educational grants from Neurocrine Biosciences, Inc. and Teva Pharmaceuticals, USA, Inc.

As conventional therapies for major depressive disorder (MDD) often leave critical gaps in symptom control and patient engagement, digital therapeutics (DTx) are emerging as valuable tools to enhance and personalize care. This session will examine the unmet needs in MDD management and explore how FDA-authorized and investigational DTx are positioned to address them. Participants will review the latest clinical guidelines, assess the evidence supporting DTx interventions, and gain practical insights into selecting, integrating, and educating patients about these innovative treatments. Attendees will leave equipped to incorporate DTx into individualized care strategies, improving access, adherence, and outcomes for patients with MDD.

Supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Gustavo Alva, MD, DFAPA

This presentation is provided by Intra-Cellular Therapies, Inc.

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Ilan Melnick, MD

This presentation is provided by Teva Pharmaceuticals USA, Inc.

Suicide remains a critical public health concern that frequently appears in clinical practice. Clinicians play a pivotal role in identifying and supporting individuals through periods of risk. This session offers a practical guide to suicide assessment and intervention, equipping psychiatric professionals with evidence-based strategies to navigate these complex clinical scenarios. Empower yourself with the tools and confidence to address suicidal ideation and behavior with your patients, ensuring compassionate and effective support during their most vulnerable moments.

The initial management of schizophrenia can shape a patient’s long-term trajectory. This session provides psychiatric professionals with essential tools and strategies for effectively managing first-episode schizophrenia. Explore evidence-based approaches to diagnosis, treatment initiation, and building therapeutic alliances. Gain practical insights into addressing common challenges, tailoring interventions, and optimizing outcomes for patients as they navigate the early stages of this complex condition. Enhance your clinical practice with knowledge that makes a lasting impact on patients' lives.

Psychedelics are redefining the landscape of psychiatric care, offering promising interventions for conditions like depression, PTSD, and addiction. This session will provide an in-depth exploration of emerging research on compounds such as ibogaine, 5-MeO-DMT, and DMT, as well as data from leading clinical trials. Attendees will gain practical insights into the expanding therapeutic potential of psychedelics beyond major depressive disorder, including their applications in treating substance use disorders and generalized anxiety. The session will also address the growing divide between medical, personal, and decriminalized uses of psychedelics, equipping clinicians with the knowledge to navigate this evolving field responsibly and effectively.

Discover cutting-edge advancements in interventional psychiatry and gain practical tools to enhance your clinical practice. This dynamic session provides a comprehensive overview of transformative treatments, including Transcranial Magnetic Stimulation (TMS), ketamine and esketamine therapy, Electroconvulsive Therapy (ECT), and vagus nerve stimulation (VNS). Participants will explore the mechanisms, indications, contraindications, and practical implementation of these interventions, as well as their role in addressing treatment-resistant psychiatric conditions. Designed specifically for early career clinicians, this session offers actionable insights and evidence-based strategies to integrate these innovative approaches into patient care, empowering you to make a meaningful impact on mental health outcomes.

Stay at the forefront of major depressive disorder (MDD) management in this engaging session tailored for psychiatric professionals. The discussion will provide a comprehensive review of current treatment options, highlighting their mechanisms, efficacy, and safety profiles. Participants will interpret pivotal clinical trials that shape contemporary MDD treatment paradigms, gaining a deeper understanding of the evidence supporting these strategies. The session will culminate in actionable guidance on applying the latest treatment recommendations, equipping clinicians with the tools to make informed, evidence-based decisions to optimize outcomes for their patients with MDD.

As cannabis legalization expands, psychiatrists are increasingly encountering patients who use or are considering using cannabis. This session provides a comprehensive crash course in cannabis, equipping clinicians with the knowledge and skills needed to navigate this evolving landscape. Explore the different strains of cannabis, their effects on the body, and the implications for mental health. Learn strategies to initiate patient-centered conversations about cannabis use, assess motivations and risks, and provide tailored education on its potential impacts, particularly in the context of co-morbidities. Gain the tools to guide your patients toward informed and safe decisions about cannabis use.

Join your peers in the Exhibit Hall to engage with mentors, recruiters, and future employers, and learn about available pharmaceuticals and devices for your practice. Have your CV reviewed by a hiring expert (booth #319), get a professional headshot taken by our photographer (booth #314), and more! Visit the Psych Congress Elevate booth (#220) to register with an exclusive Alumni rate for 2025, and to learn more about our other Psych Congress events. Elevate with the Experts Booth (#329): Jill Harkavy-Friedman, PhD; Brooke Kempf, PMHNP-BC; Ilan Melnic, MD (Faculty availability subject to change)

Join the Psych Congress Elevate Steering Committee, attendees, and peers for a poster reception with live music, hors d'oeuvres, and cocktails.

Sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.

Breakfast will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Brittany Albright MD, MPH; Todd Broder, MD; Cindy, Patient Ambassador

This presentation is provided by Axsome Therapeutics, Inc.

Join your peers and faculty for Elevate's Got Talent!

MSLs are a vital part of the chain of scientific communication between clinicians and the pharmaceutical industry. They are trusted colleagues who are firewalled off from the companies’ commercial, sales, and marketing divisions and can help connect us to valuable scientific knowledge. However, many clinicians do not fully appreciate the wealth of resources they offer or how to gain access to them. This session addresses these gaps by exploring the role MSLs play in scientific communication and how clinicians can best utilize this invaluable source of knowledge.

Join your peers in the Exhibit Hall to engage with mentors, recruiters, and future employers, and learn about available pharmaceuticals and devices for your practice. Have your CV reviewed by a hiring expert (booth #319), get a professional headshot taken by our photographer (booth #314), and more! Visit the Psych Congress Elevate booth (#220) to register with an exclusive Alumni rate for 2025, and to learn more about our other Psych Congress events. Elevate with the Experts Booth (#329): Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH; Saundra Jain, MA, PsyD, LPC; Kevin N. Williams, MS, MPAS, PA-C (Faculty availability subject to change) Coffee will also be available in the exhibit hall from 10:35 AM - 11:20 AM.

Posttraumatic stress disorder (PTSD) remains a complex and often underdiagnosed condition that profoundly impacts patients' lives. This session will provide psychiatric professionals with a comprehensive review of PTSD symptoms, prevalence, and associated burdens. Attendees will learn to utilize validated assessment tools and apply current diagnostic criteria to ensure accurate identification. The session will also highlight the latest clinical evidence and emerging treatments, empowering clinicians to make informed, evidence-based decisions. Practical strategies for implementing patient-centered and team-based care models will be discussed, equipping participants with the skills needed to optimize outcomes for individuals living with PTSD.

Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Despite significant advances, conventional monoaminergic antidepressants often fall short for patients with major depressive disorder (MDD) and treatment-resistant depression (TRD). This session will explore the limitations of traditional therapies and highlight the evolving role of innovative glutamatergic and neuromodulation approaches. Participants will review the latest clinical and real-world evidence, gain insights into mechanisms of action, and discuss the practical implications for psychiatric practice. The session will also emphasize strategies for developing personalized, patient-centered treatment plans, leveraging shared decision-making to optimize outcomes in TRD management.

Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC: a Johnson & Johnson Company.

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Ilan Melnick, MD

This presentation is provided by Otsuka America Pharmaceutical, Inc. and Lundbeck

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Lara Shirikjian, DO

This presentation is provided by Bristol Myers Squibb

Navigating ethical dilemmas in psychiatry can often feel like traversing uncharted waters, with challenges that lack clear right or wrong answers. This session delves into the nuanced ethical issues clinicians face, offering strategies to find your ethical "true north." Through engaging case examples and practical discussions, participants will explore complex scenarios such as navigating systemic barriers to care, managing dual relationships (e.g., treating multiple family members), and maintaining professional boundaries. Join this interactive session to gain tools and insights that will empower you to approach ethical gray areas with confidence and compassion, ensuring the highest standards of care for your patients.

This session delves into the intricate interplay between shame-based family systems and ADHD symptoms, offering psychiatric professionals a deeper understanding of how family dynamics influence treatment outcomes. Participants will explore evidence-based strategies to evaluate and implement comprehensive treatment options for ADHD and its commonly associated comorbidities. By integrating medication management, therapeutic interventions, and an awareness of family system dynamics, attendees will gain practical skills to craft tailored treatment plans that foster improved patient outcomes. Real-world case studies and actionable insights will ensure clinicians leave equipped to address the multifaceted needs of individuals with ADHD in their clinical practice.

Trust is the foundation of effective psychiatric care, and building rapport requires a tailored approach that acknowledges both spoken and unspoken influences on the therapeutic relationship. Every patient interaction is shaped by personal history, cultural background, and systemic factors that impact engagement in ways clinicians may not always see. This session explores strategies for fostering trust across diverse patient populations by recognizing these dynamics and adapting communication styles accordingly. Attendees will gain practical techniques to navigate resistance, strengthen therapeutic alliances, and cultivate a clinical environment where patients feel truly heard. By integrating these skills, clinicians can enhance patient outcomes and build more effective, inclusive psychiatric practices.

The rapid expansion of telepsychiatry has transformed mental health care delivery, yet evolving policies continue to shape its future. This session will provide an in-depth exploration of current telepsychiatry regulations, including licensure, reimbursement, prescribing policies, and the impact of federal and state laws. Special attention will be given to the new DEA regulations on prescribing controlled substances via telemedicine, including the end of the public health emergency flexibilities, the introduction of the special registration process, and its implications for psychiatric practice. Attendees will gain insights into the latest legislative trends, policy challenges, and strategies for ensuring compliance while optimizing patient care. Whether you are a clinician, administrator, or policymaker, this session will equip you with the knowledge needed to navigate the shifting telepsychiatry landscape effectively.

This session provides a comprehensive approach to managing bipolar disorder in patients who are pregnant or planning pregnancy. Designed for psychiatric professionals, the presentation will address the unique challenges of balancing maternal mental health with fetal safety. Attendees will explore evidence-based strategies for optimizing medication regimens, managing mood stability, and mitigating risks during the perinatal period. Practical guidance on collaborating with multidisciplinary teams and navigating complex treatment decisions will empower clinicians to support their patients in achieving the best possible outcomes for both mother and child.

Delve into the complexities of Borderline Personality Disorder (BPD) through a practical, case-based approach designed to enhance diagnostic and therapeutic skills. Participants will explore real-world scenarios to refine diagnostic skills, navigate treatment challenges, and develop effective, evidence-based strategies for patient care. Learn how to build therapeutic relationships, address co-occurring conditions, and personalize interventions to improve patient outcomes. Gain the knowledge and confidence to manage BPD with compassion and competence in your clinical practice

Join your peers in the Exhibit Hall to engage with mentors, recruiters, and future employers, and learn about available pharmaceuticals and devices for your practice. Have your CV reviewed by a hiring expert (booth #319), get a professional headshot taken by our photographer (booth #314), and more! Visit the Psych Congress Elevate booth (#220) to register with an exclusive Alumni rate for 2025, and to learn more about our other Psych Congress events. Elevate with the Experts Booth (#329): Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN; Ed Kaftarian, MD; Andrew D. Penn, MS, PMHNP-BC (Faculty availability subject to change)

Join the Psych Congress Elevate Steering Committee, attendees, and peers for a poster reception with live music, hors d'oeuvres, and cocktails. Review relevant, cutting-edge research, keep up-to-date on innovative projects and programs, and learn from your colleagues in this peer-to-peer educational format.

Breakfast will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Andrew J. Cutler, MD; Amber Hoberg, PMHNP-BC

This presentation is provided by Boehringer Ingelheim Pharmaceuticals, Inc.

Achieving optimal mental health requires more than symptom management—it demands a whole-person approach that integrates lifestyle interventions with traditional treatments. This session explores the principles of integrative psychiatry, emphasizing how lifestyle factors such as nutrition, exercise, mindfulness, and sleep can complement pharmacological interventions. Discover actionable tools to empower your patients, address their unique needs holistically, and elevate your clinical practice with a comprehensive approach to care.

Unlock the secrets to delivering memorable, scientifically valid, and impactful medical presentations in this dynamic session. Discover the top traits of effective presenters and learn how to craft a well-structured presentation that resonates with audiences. Explore best practices for every phase of a presentation and understand the art of using humor to enhance engagement. Gain unique insights from both the mentor and mentee perspectives from a pair that participated in the 2024 New & Emerging Voices speaker mentorship program at Elevate. Whether you're new to presenting or seeking to refine your skills, this session will provide actionable tips to help you master the mic.

As the understanding of depression continues to evolve, so does the need for treatment approaches that go beyond the limitations of traditional pharmacotherapy. This session will explore the challenges posed by conventional antidepressants and highlight the mechanisms of action behind novel and investigational therapies targeting depression and its associated symptoms. Through a review of the latest clinical data, psychiatric professionals will gain actionable insights into emerging treatment options and their potential to transform patient outcomes. Attendees will leave equipped to critically assess new therapies and consider their place in modern, individualized care strategies.

Supported by an educational grant from Axsome Therapeutics, Inc.

Join the Steering Committee, attendees, and peers for a Poster Lunch & Learn. Food and beverages will be served!

Sponsored by Johnson & Johnson

Delve into the complexities of anxiety disorders and discover cutting-edge strategies for effective treatment in this insightful session. This session explores the latest evidence-based approaches to diagnosing and managing anxiety disorders, from pharmacological advancements to innovative psychotherapeutic techniques. Gain practical tools and insights to optimize care and improve outcomes for patients living with the challenges of anxiety disorders.

Today social media plays a central role in adolescent life, influencing everything from self-esteem to sleep patterns. This session explores the complex relationship between social media use and adolescent mental health, examining both the benefits and risks. Learn how digital engagement impacts mood, anxiety, and self-image, while gaining practical strategies for guiding young patients and their families toward healthier online habits. Attendees will leave with evidence-based tools to navigate conversations about social media use, mitigate its negative effects, and harness its potential for positive mental health outcomes.

DOCUMENTARY SUMMARY: According to recent studies*, in addition to 5 million paid caregivers nationally, it is estimated that between 53 million to 105.6 million U.S. adults provide unpaid caregiving for ill, aging, or disabled family members and friends. In addition, an estimated 5.4 million children and adolescents in the U.S. are direct caregivers. As caregiving in America faces the twin pressures of an aging baby boomer generation and rising life expectancy, the United States’ long-term care system threatens to tip into crisis. The film will personalize this urgent national issue through stories from caregivers and interviews with experts as they fight to give caregivers the security and support they provide for so many others. The project also includes a robust national engagement campaign. The feature-length documentary and accompanying short films will examine caregiving from multiple perspectives: the creation and evolution of the care system; the social dynamics that shape our approach to caregiving today and the future possibilities; the lives of caregivers and their relationships with those in their care; the interpersonal and economic pressures faced by caregivers; and the broader societal context in which caregiving operates on the margins, yet affects everyone. *Statistics sourced from AARP, the National Alliance for Caregiving (NAC), RAND, PHI and Caregiving Youth Research Collaborative (CYRC) via the American Association of Caregiving Youth (AACY)